UTMOST, a single and cross-tissue TWAS (Transcriptome Wide Association Study), reveals new ASD (Autism Spectrum Disorder) associated genes

Abstract

Autism spectrum disorders (ASD) is a complex neurodevelopmental disorder that may significantly impact on the affected individual’s life. Common variation (SNPs) could explain about 50% of ASD heritability. Despite this fact and the large size of the last GWAS meta-analysis, it is believed that hundreds of risk genes in ASD have yet to be discovered. New tools, such as TWAS (Transcriptome Wide Association Studies) which integrate tissue expression and genetic data, are a great approach to identify new ASD susceptibility genes. The main goal of this study is to use UTMOST with the publicly available summary statistics from the largest ASD GWAS meta-analysis as genetic input. In addition, an in silico biological characterization for the novel associated loci was performed. Our results have shown the association of 4 genes at the brain level (CIPC, PINX1, NKX2-2, and PTPRE) and have highlighted the association of NKX2-2, MANBA, ERI1, and MITF at the gastrointestinal level. The gastrointestinal associations are quite relevant given the well-established but unexplored relationship between ASD and gastrointestinal symptoms. Cross-tissue analysis has shown the association of NKX2-2 and BLK. UTMOST-associated genes together with their in silico biological characterization seems to point to different biological mechanisms underlying ASD etiology. Thus, it would not be restricted to brain tissue and it will involve the participation of other body tissues such as the gastrointestinal.

Introduction

Autism spectrum disorders (ASD) includes a range of neurodevelopmental disorders (NDDs) with onset in early development that are characterized by deficits in communication and social interactions, as well as by repetitive patterns of behavior and restrictive interests¹. ASD is a complex genetic disorder, involving both environmental and genetic factors. Although an important part of the genetic architecture of ASD is unknown, it is considered that thousands of genes may be involved even most of them remain unidentified and functionally uncharacterized. Rare genetic variation only explains 3% of ASD genetic risk even if it confers a high individual risk². However, common variation (SNPs; single nucleotide polymorphisms) could explain about 50% of ASD heritability. The most recent and the largest ASD GWAS meta-analysis done until now, including 18,381 ASD cases and 27,969 controls, has reported 93 genome-wide significant markers in three separate loci (top SNP: rs910805; p-value: 2.04 × 10⁻⁹)³. Another methodological approach for common variation are gene-based association analysis (GBA) methods that employ the p-values for each SNP within a gene to obtain a single statistic at this level. Thus, MAGMA has identified 15 genes, most of them located near the genome-wide significant SNPs identified in GWAS, but 7 genes have revealed association in four additional loci (KCNN2, MMP12, NTM, and a cluster of genes on chromosome 17)³. Additional GBA methods using other algorithms as PASCAL have helped to define the association of other genes located in the same LD region than those found by MAGMA (NKX2-4, NKX2-2, CRHR1-IT1, C8orf74, and LOC644172)⁴.

In addition to GBA, bioinformatic approaches that integrate functional data are increasingly used to highlight new genes underlying GWAS summary statistics. Transcriptome-wide association studies (TWAS) have emerged as useful tools to study the genetic architecture of complex traits. Among them, MetaXcan⁵ and FUSION⁶ are well-known TWAS methods.

UTMOST (unified test for molecular signatures) has been recently reported as a novel framework for single and cross-tissue expression imputation. UTMOST is able to consider the joint effect of SNPs (summary statistics) across LD regions (1000 Genomes) and to integrate tissue expression data (GTeX) creating single and cross-tissue covariance matrices that will help to define the gene-trait associations. UTMOST performance was demonstrated at several levels and its accuracy was also well proved as it was able to identify a greater number of associations in biologically relevant tissues for complex diseases⁷.

The main aim of this paper is to further mine the summary data from the largest ASD meta-analysis using UTMOST. In addition, an in silico biological characterization for the novel associated loci will be carried out using bioinformatic approaches (DEG, pathway, gene network, and an exploratory enhancer analysis).

Overall, our results have demonstrated the association of CIPC, PINX1, NKX2-2, and PTPRE at the brain level and have also revealed the relevance of gastrointestinal tissue in ASD etiology through the association of other genes (NKX2-2, MANBA, ERI1, and MITF).

Materials and methods

Datasets

Summary statistics from the latest ASD GWAS meta-analysis were obtained from the public repository available in the PGC website (http://www.med.unc.edu/pgc/results-and-downloads). The following data set was employed: iPSYCH_PGC_ASD_Nov2017.gz (Grove et al.³) which includes the meta-analysis of ASD by the Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH) and the Psychiatric Genomics Consortium (PGC) released in November 2017. The data set comprises a total of 18,381 cases and 27,969 controls. Additional information about the genotyping, QC methods, and Ethics Commitees as well as informed consents employed in are available at the PGC website and in the previous Grove et al.³ study.

TWAS Analysis using UTMOST

UTMOST⁷ (https://github.com/Joker-Jerome/UTMOST) was run as a single tissue association test for 44 GTeX tissues (single_tissue_association_test.py) and a cross tissue association test combining gene-trait associations was run by the joint GBJ test (joint_GBJ_test.py). Both tests use the previous summary statistics of the ASD GWAS meta-analysis as an input³. UTMOST pre-calculated covariance matrices for single-tissue (covariance_tissue/) and joint test (covariance_joint/) were downloaded. Other necessary command parameters were used by default. Transcriptome-wide significance for single tissue analysis was established as p-value = 3.85 × 10⁻⁶ (0.05/12984(maximum number of genes tested) for brain tissues and p-value = 3.42 × 10⁻⁶ (0.05/14586 (maximum number of genes tested) for non-brain tissues after Bonferroni correction. Transcriptome-wide significance for joint test was established as p-value = 3.27 × 10⁻⁶ (0.05/15274) considering the number of effective test (Tables 1–3) (Supplementary.csv files for each tissue). Covariances matrices are only available for the 44 tissues of GteX v6: adipose subcutaneous, adipose visceral omentum, adrenal gland, artery aorta, artery coronary, artery tibial, brain anterior cingulate cortex BA24, brain caudate basal ganglia, brain cerebellar hemisphere, brain cerebellum, brain cortex, brain frontal cortex BA9, brain hippocampus, brain hypothalamus, brain nucleus accumbens basal ganglia, brain putamen basal ganglia, breast mammary tissue, cells EBV-transformed lymphocytes, cells transformed fibroblasts, colon sigmoid, colon transverse, esophagus gastroesophageal junction, esophagus mucosa, esophagus muscularis, heart atrial appendage, heart left ventricle, liver, lung, muscle skeletal, nerve tibial, ovary, pancreas, pituitary, prostate, skin not sun-exposed suprapubic, skin sun-exposed lower leg, small intestine, terminal ileum, spleen, stomach, testis, thyroid, uterus, vagina, whole blood.

Table 1.

UTMOST Single tissue analysis (Brain tissues).

Loci	Location hg19	MinP (UTMOST)	Tissue	Z score	SNPs in model	Other associations GWAS, GBA and/or TWAS
PTPRE	chr10:129705325-129884164	1.53 × 10−6	Brain cortex	−4.8	6	–
CIPC*	chr14:77564601-77583630	3.82 × 10−6	Brain hipoccampus	−4.62	19	–
NKX2-2	chr20:21491660-21494664	9.38 × 10−9	Brain nucleo accubens basal ganglia	−5.74	62	Grove et al./Alonso-Gonzalez et al.
PINX1*	chr8:10622884-10697299	3.82 × 10−6	Brain nucleo accubens basal ganglia	4.62	14	Grove et al./Alonso-Gonzalez et al. (neighbour gene C8orf74)

List of independent significant loci.

Bonferroni threshold <3.85 × 10⁻⁶.

GWAS genome-wide association study, SNP single nucleotide polymorphism, TWAS transcriptome-wide association study.

*Marginally significant.

Table 3.

UTMOST Cross tissue analysis.

Loci	Location hg19	MinP (UTMOST)	test score	Other associations GWAS, GBA and/or TWAS
BLK	chr8:11351521-11422108	2.85 × 10−6	12.3	Grove et al.
NKX2-2	chr20:21491660-21494664	3.7 × 10−7	13.9	Grove et al./Alonso-Gonzalez et al.

List of independent significant loci.

Bonferroni threshold = 3.27 × 10⁻⁶.

GWAS genome-wide association study, SNP single nucleotide polymorphism, TWAS transcriptome-wide association study.

Morpheus software (https://software.broadinstitute.org/morpheus/) was used to display the Z scores of UTMOST significant genes across GTeX Brain tissues. UTMOST significance as a Z score in brain tissues is ∼4.6. Gray squares in the heatmap indicate that the gene weights were not available in the target tissue (Fig. 1).

Fig. 1. Heatmap representing UTMOST significant genes across weight sets and brain areas.

UTMOST significance as a Z score is ~4.6. Gray squares indicate that gene weights were not available in the target tissue.

DEG and gene expression analysis with FUMA

GENE2FUNC, a tool of FUMA⁸ (https://fuma.ctglab.nl/), was employed to carry out a gene expression heatmap and an enrichment analysis of differentially brain expressed genes (DEG) using BrainSpan RNA-seq data. Those genes represented in Table 4 (bold: PTPRE, CIPC, NKX2-2, PINX1) were used as an input. Expression values are TPM (Transcripts Per Million) for GTEx v6 and RPKM (Read Per Kilobase per Million). In order to define DEG sets, two-sided Student’s t-test were performed for these genes and per tissue against the different tissue types or developmental stages. Those genes with a p-value < 0.05 after Bonferroni correction and a log fold change ≥0.58 are defined as DEG. The direction of expression was considered. The −log10 (p-value) refers to the probability of the hypergeometric test DEG analysis was carried out creating differentially expressed genes for each expression data set (Fig. 2). Heatmaps display the normalized expression value (zero mean normalization of log2 transformed expression), and darker red means higher relative expression of that gene in each label, compared to a darker blue color in the same label (Fig. 3).

Table 4.

List of associated genes for each analysis (bold) and their predicted GeneMANIA interactors that were used as input for Metascape analysis.

UTMOST Single brain	UTMOST Single Gastrointestinal	UTMOST Cross analysis
CIPC	NKX2-2	NKX2-2
PINX1	MANBA	BLK
NKX2-2	ERI1	NKX6-1
PTPRE	MITF	IAPP
NKX6-1	NKX6-1	MAFA
PTGES3	TYRP1	EGFR
DKC1	TFE3	PAX6
IAPP	IAPP	OLIG2
MAFA	TYR	PDX1
TERT	MAFA	SYK
LMO4	PAX6	TRPV6
GTPBP4	TFEB	TDGF1
SRC	LEF1	CD79B
PDGFRB	HNRNPD	GAB1
IL6R	GUSB	EPHA6
PAX6	PIAS3	PLCG2
IL6	CREB3L4	BLNK
OLIG2	UBE2I	KIT
TERF1	CREB3L3	CD79A
PDX1	CREB3L2	NEUROG3
HSP90AA1	CREB3L1	AR
SHC1	TFEC	EPHA5
DHX15	SLBP
CALM1	OLIG2

Fig. 2. DEG analysis for PTPRE, CIPC, PINX1 and NKX2-2.

a DEG using BrainSpan 11 general developmental stages of brain samples and b DEG using BrainSpan 29 different ages of brain data. There are not significantly enriched DEG sets.

Fig. 3. Gene expression heatmaps for PTPRE, CIPC, PINX1 and NKX2-2.

a Gene expression heatmap using BrainSpan 11 general developmental stages of brain samples and b BrainSpan 29 differentes ages of brain data. Genes are ordered by expression clusteres and brain samples and ages by alphabetical order.

GeneMANIA and Metascape analysis

GeneMANIA⁹ (https://genemania.org/) was used to build a gene network for the UTMOST-associated genes by the single tissue analysis (brain and gastrointestinal tissues) and by the joint tissue analysis (Table 4). Each gene-network was subsequently analyzed with Metascape (https://metascape.org/)¹⁰ to carry out a pathway enrichment and a protein–protein interaction enrichment using the Evidence Counting (GPEC) prioritization tool. For each given gene list, pathway and process enrichment analysis has been carried out with the following ontology sources: GO biological processes, GO cellular components and GO molecular functions. The enrichment background includes all the genes in the genome. Terms with a p-value < 0.01, a minimum count of 3, and an enrichment factor >1.5 (the enrichment factor is the ratio between the observed counts and the counts expected by chance) are collected and grouped into clusters based on their membership similarities. More specifically, p-values are calculated based on the accumulative hypergeometric distribution, and q-values are calculated using the Benjamini–Hochberg procedure to account for multiple testings. Kappa scores are used as the similarity metric when performing hierarchical clustering on the enriched terms, and sub-trees with a similarity of >0.3 are considered a cluster. We select the terms with the best p-values from each of the 20 clusters, with the constraint that there are no more than 15 terms per cluster and no more than 250 terms in total (Figs. 4–6). The network is visualized using Cytoscape, where each node represents an enriched term and is colored first by its cluster ID (or each given gene list, protein–protein interaction enrichment analysis has been carried out with the following databases: BioGrid6, InWeb_IM7, OmniPath8. The resultant network contains the subset of proteins that form physical interactions with at least one other member in the list. If the network contains between 3 and 500 proteins, the Molecular Complex Detection (MCODE) algorithm has been applied to identify densely connected network components. The MCODE networks identified for individual gene lists are shown in Figs. 4–6.

Fig. 4. Gene networks, enriched ontology clusters, and PPI interaction analysis fot the brain-associated genes (CIPC, PINX1, NKX2-2, and PTPRE) by UTMOST (single tissue analysis).

a GeneMania gene network. b Bar graph of enriched terms across input gene lists, colored by p-values. c Network of enriched terms: colored by cluster ID, where nodes that share the same cluster ID are typically close to each other. d Protein–protein interaction network and MCODE components identified in the gene lists. (MCODE1:red).

Fig. 6. Gene network, enriched ontology clusters, and PPI interaction analysis for the associated genes by UTMOST cross. tissue analysis (BLK and NKX2-2) and their interactors.

a GeneMania gene network. b Bar graph of enriched terms across input gene lists, colored by p-values. c Network of enriched terms: colored by cluster ID, where nodes that share the same cluster ID are typically close to each other. d Protein–protein interaction network and MCODE components identified in the gene lists (MCODE1:red).

Enhancer analysis (dbSUPER)

dbSUPER (https://asntech.org/dbsuper/) was used to perform an exploratory enhancer analysis for the UTMOST-associated genes (single-tissue analysis) and for those tissues (brain and gastrointestinal) available at dbSUPER. The parameters selected were: SEs ranking method (H3K27ac), the peak calling was done with MACS (version 1.4.1) with parameters -p 1e-9,-keep-dup = auto, -w -S -space = 50, the stitching distance was established at 12,5 kb, the TSS exclusive zone was set at ±2 kb and the enhancer gene assignment was done within a 50 kb window.

Results and discussion

UTMOST analyses and comparison with previous results

UTMOST single tissue analysis (Brain tissues) showed association of two loci, NKX2-2 and PTPRE, while other two loci, CIPC and PINX1, showed a marginal association according to Bonferroni threshold (Table 1, Supplementary.csv files). NKX2-2 was previously identified as an associated gene by two different GBA algorithms, MAGMA, and PASCAL^3,4. The results obtained by UTMOST also serve to indicate the nucleus accumbens basal ganglia as the brain area in which these genes may be acting. Although the association of PTPRE was not obtained as such in previous analyses, the association of its neighboring gene, C8orf74, was noted in a previous study and one of the index SNPs in the latest ASD GWAS was located near PINX1 (rs10099100) (Supplementary Fig. 1a, b)^3,4.

NKX2-2 was also marginally associated by UTMOST within non-brain tissue together with other genes. It should be noted that some genes are tissue-specific for gastric and intestinal tissues such as stomach, esophagus and colon (MANBA, ERI1, MITF, and NKX2-2). The association of NKX2-2 in colon is noteworthy because NKX2-2 was previously reported as an ASD risk gene and now it is highlighted again by UTMOST in brain tissues. It seems that NKX2-2 together with BLK may play a role in ASD etiology but not only at the brain level since UTMOST cross-tissue analysis also found association for both genes (Tables 2, 3, Supplementary Figs. 1a, 2a, b, Supplementary.csv files)

Table 2.

UTMOST Single tissue analysis (Non Brain tisues).

Loci	Location hg19	MinP (UTMOST)	Tissue	Z score	SNPs in model	Other associations GWAS, GBA and/or TWAS
NKX2-2*	chr20:21491660-21494664	5.28 × 10−6	Colon transverse	−4.55	2	Grove et al./Alonso-Gonzalez et al.
MANBA	chr4:103552643-103682151	3.2 × 10−6	Esophagus muscularis	4.66	47	–
ERI1*	chr8:8860314-8890849	3.84 × 10−6	Esophagus muscularis	4.62	124	–
DOK5	chr20:53092266-53267710	4.86 × 10−7	Liver	−409.74	4	–
ATXN1	chr6:16299343-16761721	2.4 × 10−6	Nerve tibial	−4.72	27	–
FERMT2	chr14:53323989-53417815	3.1 × 10−6	Skin not sun exposed	−5.49	14	–
MITF	chr3:69788586-70017488	2.34 × 10−6	Stomach	4.72	111	–
CTSB	chr8:11700034-11725646	3.36 × 10−6	Thyroid	4.65	66	–
ANGEL1	chr14:77253586-77279283	1.89 × 10−6	Uterus	4.76	83	–

List of independent significant loci.

Bonferroni threshold = 3.42 × 10⁻⁶.

Genes in bold are associated within gastrointestinal tissues.

GWAS genome-wide association study, SNP single nucleotide polymorphism, TWAS transcriptome-wide association study.

*Marginally significant.

To evaluate the importance of each brain tissue in ASD etiology, a secondary analysis was performed using Z scores values for each ASD-associated gene across GTeX brain tissues. The heatmap showed that there is a wide specificity of association in terms of Z score for each gene and brain tissue indicating the importance of conducting tissue specific analyses such as UTMOST (Fig. 1).

DEG analysis with GENE2FUNC tool (FUMA)

DEG Analysis with BrainSpan data (11 general developmental stages of brain samples and 29 different ages of brain samples) for the brain associated set of genes have not shown any significant result (Fig. 2a, b). However, CIPC have shown overexpression across every single developmental stage in comparison with the remaining ASD-associated genes (Fig. 3a, b).

GeneMANIA and Metascape analysis

GeneMANIA was used to find out the possible interactors with the associated genes (Table 4). We have proposed three different analyses. One based on the genes associated in brain tissues; another one based on the associated genes at a gastrointestinal level, given the associations pointed out by UTMOST and the previous implications of gastrointestinal abnormalities and symptoms in ASD and the lack of biological knowledge about them. The final analysis is focused on the genes identified by the cross-tissue analysis and their interactors. The general goal is to delineate the biological pathways underlying each group of genes and the differences between them.

Gene network, enriched ontology clusters, and PPI interaction analysis for the brain-associated genes (CIPC, PINX1, NKX2-2, and PTPRE) by UTMOST Single tissue analysis and their interactors highlights different biological pathways mainly involved in telomere maintenance and transcription regulation (Tables 5, 6 and Fig. 4). However, associated genes in gastrointestinal tissue (NKX2-2, MANBA, ERI1, and MITF) and their interactors mainly regulate DNA transcription by RNA polymerase II and the fate of oligodendrocytes. This is an interesting finding given the possible involvement of these cells in the enteric nervous system in ASD (Tables 7, 8 and Fig. 5). Finally, NKX2-2 and BLK both associated in the cross-tissue analysis, seem to point to very diverse biological pathways such as protein tyrosine kinase activity, B cell receptor complex, regulation of DNA-binding transcription factor activity, and neuron projection morphogenesis, among others (Tables 8–10 and Fig. 6).

Table 9.

Top 11 clusters with their representative enriched terms (one per cluster) fot the associated genes by UTMOST Cross Tissue Analysis (BLK and NKX2-2) and their predicted interactors.

GO	Category	Description	Count	%	Log10(P)	Log10(q)
GO:0004713	GO Molecular functions	Protein tyrosine kinase activity	6	42.86	−10.03	−5.68
GO:0031018	GO Biological processes	Endocrine pancreas development	5	25.00	−9.57	−5.64
GO:0019815	GO Cellular components	B cell receptor complex	3	21.43	−9.21	−5.56
GO:0051090	GO Biological processes	Regulation of DNA-binding transcription factor activity	7	35.00	−7.40	−4.63
GO:0030072	GO Biological processes	Peptide hormone secretion	6	30.00	−7.37	−4.63
GO:0007263	GO Biological processes	Nitric oxide mediated signal transduction	3	21.43	−6.25	−3.89
GO:0048812	GO Biological processes	Neuron projection morphogenesis	7	35.00	−6.21	−3.87
GO:0051897	GO Biological processes	Positive regulation of protein kinase B signaling	4	20.00	−4.91	−2.92
GO:0019904	GO Molecular functions	Protein domain specific binding	5	35.71	−4.45	−2.58
GO:0072507	GO Biological processes	Divalent inorganic cation homeostasis	4	18.18	−2.92	−1.26
GO:0001568	GO Biological processes	Blood vessel development	4	18.18	−2.31	−0.69

“Count” is the number of genes in the user-provided lists with membership in the given ontology term. “%“ is the percentage of all of the provided genes that are found in the given ontology term (only input genes with at least one ontology term annotation are included in the calculation). “Log10(P)” is the p-value in log base 10. “Log10(q)” is the multi-test adjusted p-value in log base 10.

Table 5.

Top 11 clusters with their representative enriched terms (one per cluster) for the associated genes (CIPC PINX1, NKX2-2, and PTPRE) (Single tissue analysis (Brain)) and their interactors.

GO	Category	Description	Count	%	Log10(P)	Log10(q)
GO:0007004	GO Biological processes	Telomere maintenance via telomerase	7	43.75	−13.85	−9.50
GO:0031018	GO Biological processes	Endocrine pancreas development	6	26.09	−11.54	−8.33
GO:0051347	GO Biological processes	Positive regulation of transferase activity	8	50.00	−8.34	−5.76
GO:0070851	GO Molecular functions	Growth factor receptor binding	5	31.25	−7.69	−5.24
GO:0031647	GO Biological processes	Regulation of protein stability	6	26.09	−6.61	−4.30
GO:0051098	GO Biological processes	Regulation of binding	6	26.09	−6.00	−3.83
GO:0010035	GO Biological processes	Response to inorganic substance	6	37.50	−5.98	−3.83
GO:0019904	GO Molecular functions	Protein domain specific binding	6	37.50	−5.40	−3.36
GO:0050999	GO Biological processes	Regulation of nitric−oxide synthase activity	3	18.75	−5.31	−3.29
GO:0009636	GO Biological processes	Response to toxic substance	6	26.09	−5.08	−3.10
GO:0019932	GO Biological processes	Second-messenger-mediated signaling	4	17.39	−3.12	−1.51

“Count” is the number of genes in the user-provided lists with membership in the given ontology term. “%“ is the percentage of all of the provided genes that are found in the given ontology term (only input genes with at least one ontology term annotation are included in the calculation). “Log10(P)” is the p-value in log base 10. “Log10(q)” is the multi-test adjusted p-value in log base 10.

Table 6.

Protein–protein interaction network and MCODE components identified in the gene lists for the associated genes (CIPC PINX1, NKX2-2, and PTPRE) (Single tissue analysis (Brain)) and their interactors.

GO	Description	Log10(P)	MCODE	GO	Description	Log10(P)
GO:0007004	Telomere maintenance via telomerase	−13.0	MCODE_1	GO:0007169	Transmembrane receptor protein tyrosine kinase signaling pathway	−4.5
GO:0006278	RNA-dependent DNA biosynthetic process	−12.7	MCODE_2	GO:0007004	Telomere maintenance via telomerase	−7.6
			MCODE_2	GO:0006278	RNA-dependent DNA biosynthetic process	−7.5
GO:0010833	Telomere maintenance via telomere lengthening	−12.5	MCODE_2	GO:0010833	Telomere maintenance via telomere lengthening	−7.4

Table 7.

Top 4 clusters with their representative enriched terms (one per cluster) fot the associated genes by UTMOST Single tissue analysis (GI tissues) (NKX2-2, MANBA, ERI1, and MITF) and their predicted interactors.

GO	Category	Description	Count	%	Log10(P)	Log10(q)
GO:0000978	GO Molecular functions	RNA polymerase II proximal promoter sequence-specific DNA binding	12	57.14	−13.89	−9.63
GO:0021778	GO Biological processes	Oligodendrocyte cell fate specification	3	25.00	−9.03	−5.82
GO:0048066	GO Biological processes	Developmental pigmentation	4	33.33	−8.21	−5.12
GO:0008134	GO Molecular functions	Transcription factor binding	6	28.57	−4.81	−2.47

“Count” is the number of genes in the user-provided lists with membership in the given ontology term. “%“ is the percentage of all of the provided genes that are found in the given ontology term (only input genes with at least one ontology term annotation are included in the calculation). “Log10(P)” is the p-value in log base 10. “Log10(q)” is the multi-test adjusted p-value in log base 10.

Table 8.

Protein–protein interaction network and MCODE components identified in the gene lists for the GI associated genes (and their interactors.

GO	Description	Log10(P)	MCODE	GO	Description	Log10(P)
GO:0000978	RNA polymerase II proximal promoter sequence-specific DNA binding	−11.2	MCODE_1	GO:0035497	cAMP response element binding	−9.8
GO:0000987	proximal promoter sequence-specific DNA binding	−11.0	MCODE_1	GO:0030968	Endoplasmic reticulum unfolded protein response	−6.9
GO:0001228	DNA-binding transcription activator activity, RNA polymerase II-specific	−10.8	MCODE_1	GO:0034620	Cellular response to unfolded protein	−6.7

Fig. 5. Gene networks, enriched ontology clusters for the associated genes by UTMOST single tissue analysis (gastrointestinal tissues) and their predicted interactors (NKX2-2, MANBA, ERI1, MITF).

a GeneMania gene network. b Bar graph of enriched terms across input gene lists, colored by p-values. c Network of enriched terms: colored by cluster ID, where nodes that share the same cluster ID are typically close to each other.

Table 10.

Protein–protein interaction network and MCODE components identified in the gene lists for the cross analysis associated genes and their interactors.

GO	Description	Log10(P)	MCODE	GO	Description	Log10(P)
GO:0030183	B cell differentiation	−9.6	MCODE_1	GO:0030183	B cell differentiation	−9.1
GO:0004713	Protein tyrosine kinase activity	−9.4
GO:0007169	Transmembrane receptor protein tyrosine kinase signaling pathway	−9.4	MCODE_1	GO:0042113	B cell activation	−7.5
			MCODE_1	GO:0030098	Lymphocyte differentiation	−7.3

Enhancer analysis (dbSUPER)

Given the tissue specificity given by UTMOST associations, we found interesting to perform an exploratory analysis of enhancers. According to the dbSUPER dabase only CIPC could work as a superenhancer in the brain middle hippocampus (SE_06106; chr14: 77562660-77607123, size: 44463 pb) (Supplementary Fig. 3).

As far as we know, this is the first study that has employed the UTMOST framework combined with the summary statistics of the largest ASD meta-analysis. The main aim was to identify ASD tissue-specific genes in brain and/or other tissues. It should be noted at the outset that gene-level associations identified by UTMOST do not imply causality. However, looking at the regional plots for each loci associated by UTMOST, the results shown at brain and gastrointestinal level seems pretty consistent. Thus, UTMOST has served to identify new ASD-associated genes in brain tissues as PTPRE and CIPC. Furthermore, UTMOST has been useful to confirm and obtain information on the tissue in which other known ASD risk genes such as NKX2-2 and PINX1 may have functional relevance. Altogether, brain-associated genes seems to point to three brain areas: cortex, hippocampus and nucleo accumbens. Previous studies demonstrated the ASD-associated gene expression in brain cortex¹¹. In addition, hippocampus underlie some of the featured social memory and cognitive behaviors both crucial aspects in ASD¹². The nucleus accumbens is a key brain area also related with the social reward response in ASD¹³. It should be also noted some limitations of our study. UTMOST uses GTeX v6 data by default and it should be interesting to re-run the analysis once the tool will be updated. Thus, UTMOST could find novel associated genes when expression data from other relevant ASD brain tissues as the amygdala are included. Another limitation of our results is the small number of SNPs considered by UTMOST to create the statistic in some genes (PTPRE in brain tissues and NKX2-2 in non-brain tissues analysis). However, we have been very conservative in establishing Bonferroni correction for all tissues in an analysis group. Thus, for example, we always chose the maximum number of genes tested in one of the brain tissues and applied this to calcule Bonferroni for the whole group of brain tissues as a whole.

In relation to the biological pathways in which UTMOST-associated genes are involved, our results open possible avenues for future genetic and functional studies. Thus, the functional role in ASD of CIPC, PINX1, NKX2-2, and PTPRE has not yet been characterized in detail. Metascape analysis have provided an insight revealing their involvement in telomerase maintenance and transcription regulation. Thus, PINX1 (PIN2 (TERF1) Interacting Telomerase Inhibitor 1) enhances TRF1 binding to telomeres and inhibits telomerase activity. It was proved that its silencing compromises telomere length maintenance in cancer cells¹⁴. In addition, it was recently found that children with ASD and sensory symptoms have shorter telomeres, compared to those children exhibiting a typical development¹⁵. CIPC (CLOCK interacting pacemaker) is a mammalian circadian clock protein. Recently, circadian rithms were pointed out as involved in brain development and they could underly ASD etiology due to its implication in behavioral processes. Circadian rythms are regulated through several transcription factors in different cellular types, fact that might be related with the GO terms associated with transcription regulation in this study¹⁶. Moreover, the result of CIPC as a predicted superenhancer highlights its possible functional repercussion.

UTMOST found association of several genes in non-brain tissues. However, we found really interesting to study those genes related to gastrointestinal tissues (NKX2-2, MANBA, ERI1, and MITF). There is a well-known and established comorbidity among gastrointestinal symptoms and ASD¹⁷. These clinical associations suggest the implication of gastrointestinal populations of neuronal cells. A mutation in NLGN3 (R451C) has been recently identified in two ASD brothers with GI symptoms. Mice models have demonstrated that R451C alter the number of neuronal cells in the small intestine and impact fecal microbes¹⁸. These evidence suggest that the role of NKX2-2, MANBA, ERI1, and MITF in gastrointestinal tissue should be further studied.

BLK and NKX2-2 are both associated in the cross-tissue analysis. The importance of UTMOST approach is that is able to show the association of two previously known ASD risk genes but not restricted to brain tissue. These findings lead to a difficult question whether autism can be a multisystemic disorder, something that has been recently pointed out by some authors¹⁹.

In conclusion, UTMOST, a novel single and cross-tissue TWAS, has revealed new ASD-associated genes. These genes have been characterized at the pathway and gene network level using bioinformatic approaches. However, future tissue-specific functional studies will be key to properly determine their role in ASD etiology.

Conflict of interest

The authors declare no competing interests.

Supplementary information

The online version contains supplementary material available at 10.1038/s41398-021-01378-8.